Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IofinaFRA:IF7 +4.76%74 Receivables Turnover is 2.57 as of Dec. 2025. GuruFocus rates FRA:IF7 with a GF Score™ of 74/100 and a GF Value™ of €0.30 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,577 Chemicals companies, Iofina ranks worse than 60.94% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Iofina's Revenue for the
six
months ended in Dec. 2025 was €31.90 Mil. Iofina's average Accounts Receivable for the
six
months ended in Dec. 2025 was €12.43 Mil.
Hence, Iofina's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.57.
Iofina (FRA:IF7) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Iofina Receivables Turnover Related Terms
Iofina Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Iofina's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:IF7 vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Iofina's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iofina Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Iofina's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Iofina's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Iofina (FRA:IF7) has a Receivables Turnover of 2.57 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Iofina and its competitors. According to the industry distribution chart, Iofina ranks #961 out of 1577 companies in the Chemicals industry, placing it in the top 60.9%.
Is Iofina's Receivables Turnover too high?
Iofina's current Receivables Turnover is 2.57. The Chemicals industry median Receivables Turnover is 5.59. Iofina's value of 2.57 is 54% below this industry median. Based on the distribution chart, Iofina ranks #961 out of 1577 companies in the Chemicals industry, which is below the industry midpoint. Overall, Iofina has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Iofina's Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Iofina ranks #961 out of 1577 companies for Receivables Turnover. This places Iofina in the lower half of its industry. The industry median Receivables Turnover is 5.59. Iofina's value of 2.57 is 54% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.59, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Iofina's current Receivables Turnover of 2.57 is 54% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Iofina and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Iofina's current Receivables Turnover is 2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iofina stock overvalued right now?
Based on GuruFocus' analysis, Iofina (FRA:IF7) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.30, compared to a current price of €0.66 — trading 120% above its estimated fair value. The current Receivables Turnover is 2.57 and 54% below the Chemicals industry median of 5.59. Iofina's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Iofina (FRA:IF7), the current Receivables Turnover is 2.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Iofina (FRA:IF7) Overvalued in 2026?
Based on GuruFocus' analysis, Iofina stock appears to be overvalued.
The current stock price of €0.66 is trading 120% above its estimated GF Value™ of €0.30.
GuruFocus considers Iofina to be Significantly Overvalued.
Key valuation signals for FRA:IF7:
Receivables Turnover: 2.57
GF Value™: €0.30 vs. price of €0.66 (120% above fair value)
Industry Position: 54% below the Chemicals median (#961 of 1577)
No single metric tells the full story. See the FRA:IF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iofina PLC is a holding company engaged in the exploration and isolation of iodine and the production of specialty chemicals. The company's operating segment includes Halogen Derivatives & Iodine and Hemp seeds. Its geographical segments include the United States of America and the United Kingdom and it derives a majority of its revenue from the North America.
74GF Score
Get the complete analysis for FRA:IF7
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IF7 has been successfully added to your 
